Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 30 Apr 2026 | 31 Jan 2026 | 31 Jul 2025 | 30 Apr 2025 | 31 Jan 2025 | 31 Jul 2024 |
|---|---|---|---|---|---|---|
| Revenue | 21M | 19M | 20M | 19M | 19M | 17M |
| Cost of revenue | 13M | 13M | 13M | 13M | 13M | 12M |
| Gross profit | 7M | 6M | 7M | 6M | 6M | 5M |
| Research and development | 915,000 | 852,000 | 759,000 | 683,000 | 682,000 | 653,000 |
| Selling, general and administrative | 5M | 5M | 5M | 5M | 5M | 5M |
| Operating expenses | 6M | 6M | 6M | 6M | 6M | 5M |
| Operating income | 1M | 177,000 | 719,000 | 106,000 | 56,000 | −419,000 |
| Pre-tax income | 939,000 | −16,000 | 480,000 | −110,000 | −209,000 | −757,000 |
| Income tax | 60,000 | 34,000 | 88,000 | 135,000 | 36,000 | −52,000 |
| Net income | 879,000 | −50,000 | 392,000 | −245,000 | −245,000 | −705,000 |
| Earnings per share | 0.08 | 0.00 | 0.04 | −0.02 | −0.02 | −0.07 |
| Earnings per share, diluted | 0.08 | 0.00 | 0.04 | −0.02 | −0.02 | −0.07 |
| Weighted average shares | 11M | 11M | 11M | 11M | 11M | 10M |
| Weighted average shares, diluted | 11M | 11M | 11M | 11M | 11M | 10M |
| Metric | 30 Apr 2026 | 31 Jan 2026 | 31 Oct 2025 | 31 Jul 2025 | 30 Apr 2025 | 31 Jan 2025 | 31 Oct 2024 | 31 Jul 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 3M | 5M | 5M | 3M | 4M | 1M | 839,000 | 2M |
| Receivables | 16M | 13M | 15M |
| Metric | 31 Jan 2026 | 31 Jul 2025 | 30 Apr 2025 | 31 Jan 2025 | 31 Jul 2024 |
|---|---|---|---|---|---|
| Operating cash flow | 867,000 | — | — | 601,000 | — |
| Depreciation and amortisation | 618,000 | — | — | 616,000 | — |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 15M |
| 15M |
| 13M |
| 12M |
| 11M |
| Inventory | 14M | 14M | 14M | 14M | 13M | 13M | 15M | 15M |
| Current assets | 35M | 33M | 35M | 34M | 33M | 30M | 29M | 29M |
| Property, plant and equipment | 4M | 4M | 4M | 4M | 4M | 5M | 5M | 5M |
| Goodwill | 8M | 8M | 8M | 8M | 8M | 8M | 8M | 8M |
| Total assets | 72M | 70M | 73M | 73M | 73M | 70M | 71M | 72M |
| Current liabilities | 19M | 18M | 21M | 21M | 21M | 18M | 18M | 18M |
| Short-term debt | — | — | — | — | — | — | 0 | 0 |
| Long-term debt | — | — | — | — | — | — | 0 | 0 |
| Total liabilities | 35M | 35M | 38M | 38M | 39M | 36M | 37M | 38M |
| Equity | 37M | 36M | 35M | 35M | 34M | 34M | 34M | 34M |
| Shares outstanding | 11M | 11M | 11M | 11M | 11M | 11M | 11M | 10M |
| Shares issued | 11M | 11M | 11M | 11M | 11M | 11M | 11M | 10M |
| Share-based compensation |
| 264,000 |
| — |
| — |
| 195,000 |
| — |
| Capital expenditure | 218,000 | 108,000 | 34,000 | 27,000 | 252,000 |
| Investing cash flow | −218,000 | — | — | −27,000 | — |
| Financing cash flow | −620,000 | — | — | −140,000 | — |